Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 538529, 18 pages
http://dx.doi.org/10.1155/2015/538529
Research Article

Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions

1Department of Cell Biology, Institute of Biology, UNICAMP, Avenue Bertrand Russel, 6109 Campinas, SP, Brazil
2Department of Clinical Sciences, Division of Urological Research, Skåne University Hospital, Lund University, 205 02 Malmö, Sweden
3Department of Biology, Institute of Biosciences, Humanities and Exact Sciences, UNESP, São José do Rio Preto, SP, Brazil

Received 13 May 2015; Revised 22 June 2015; Accepted 24 June 2015

Academic Editor: Hiroshi Okamoto

Copyright © 2015 Marina G. Gobbo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Reiter and D.-X. Tan, “Melatonin: a multitasking molecule,” Progress in Brain Research, vol. 181, pp. 127–151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Reiter, D.-X. Tan, L. C. Manchester, S. D. Paredes, J. C. Mayo, and R. M. Sainz, “Melatonin and reproduction revisited,” Biology of Reproduction, vol. 81, no. 3, pp. 445–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. L. Montilla, J. F. Vargas, I. F. Túnez, M. C. Muñoz, M. E. D. Valdelvira, and E. S. Cabrera, “Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin,” Journal of Pineal Research, vol. 25, no. 2, pp. 94–100, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. S. R. Pandi-Perumal, V. Srinivasan, G. J. M. Maestroni, D. P. Cardinali, B. Poeggeler, and R. Hardeland, “Melatonin: nature's most versatile biological signal?” FEBS Journal, vol. 273, no. 13, pp. 2813–2838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Reiter, “Melatonin: lowering the high price of free radicals,” News in Physiological Sciences, vol. 15, no. 5, pp. 246–250, 2000. View at Google Scholar · View at Scopus
  6. H. Vural, T. Sabuncu, S. O. Arslan, and N. Aksoy, “Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats,” Journal of Pineal Research, vol. 31, no. 3, pp. 193–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Mohan, K. Sadeghi, R. J. Reiter, and M. L. Meltz, “The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappaB,” Biochemistry and Molecular Biology International, vol. 37, no. 6, pp. 1063–1070, 1995. View at Google Scholar · View at Scopus
  8. F. Radogna, M. Diederich, and L. Ghibelli, “Melatonin: a pleiotropic molecule regulating inflammation,” Biochemical Pharmacology, vol. 80, no. 12, pp. 1844–1852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Becker-André, I. Wiesenberg, N. Schaeren-Wiemers et al., “Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily,” The Journal of Biological Chemistry, vol. 269, no. 46, pp. 28531–28534, 1994. View at Google Scholar · View at Scopus
  10. I. Wiesenberg, M. Missbach, J.-P. Kahlen, M. Schrader, and C. Carlberg, “Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand,” Nucleic Acids Research, vol. 23, no. 3, pp. 327–333, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Acuna-Castroviejo, G. Escames, M. I. Rodriguez, and L. C. Lopez, “Melatonin role in the mitochondrial function,” Frontiers in Bioscience, vol. 12, no. 3, pp. 947–963, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Benítez-King, L. Huerto-Delgadillo, and F. Antón-Tay, “Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma N1E-115 cells,” Journal of Pineal Research, vol. 9, no. 3, pp. 209–220, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Nosjean, M. Ferro, F. Cogé et al., “Identification of the melatonin-binding site MT3 as the quinone reductase 2,” The Journal of Biological Chemistry, vol. 275, no. 40, pp. 31311–31317, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Gilad, M. Laudon, H. Matzkin, and N. Zisapel, “Evidence for a local action of melatonin on the rat prostate,” Journal of Urology, vol. 159, no. 3, pp. 1069–1073, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Paroni, L. Terraneo, F. Bonomini et al., “Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling,” Journal of Pineal Research, vol. 57, no. 1, pp. 43–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. W. F. Siu, K. W. Lau, P. C. Tam, and S. Y. W. Shiu, “Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity,” Prostate, vol. 52, no. 2, pp. 106–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. C. Xi, S. W. F. Siu, S. W. Fong, and S. Y. W. Shiu, “Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression,” Prostate, vol. 46, no. 1, pp. 52–61, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Marelli, P. Limonta, R. Maggi, M. Motta, and R. M. Moretti, “Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells,” Prostate, vol. 45, no. 3, pp. 238–244, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. R. M. Moretti, M. M. Marelli, R. Maggi, D. Dondi, M. Motta, and P. Limonta, “Antiproliferative action of melatonin on human prostate cancer LNCaP cells,” Oncology Reports, vol. 7, no. 2, pp. 347–351, 2000. View at Google Scholar · View at Scopus
  20. J.-W. Park, M.-S. Hwang, S.-I. Suh, and W.-K. Baek, “Melatonin down-regulates HIF-1α expression through inhibition of protein translation in prostate cancer cells,” Journal of Pineal Research, vol. 46, no. 4, pp. 415–421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Rimler, Z. Culig, G. Levy-Rimler et al., “Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity,” Prostate, vol. 49, no. 2, pp. 145–154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Rimler, Z. Culig, Z. Lupowitz, and N. Zisapel, “Nuclear exclusion of the androgen receptor by melatonin,” Journal of Steroid Biochemistry and Molecular Biology, vol. 81, no. 1, pp. 77–84, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. E. J. Sohn, G. Won, J. Lee, S. Lee, and S.-H. Kim, “Upregulation of miRNA3195 and miRNA374b mediates the anti-angiogenic properties of melatonin in hypoxic PC-3 prostate cancer cells,” Journal of Cancer, vol. 6, no. 1, pp. 19–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. W. Tam, K. W. Chan, V. W. S. Liu, B. Pang, K.-M. Yao, and S. Y. W. Shiu, “Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance,” Journal of Pineal Research, vol. 45, no. 4, pp. 403–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. W. Tam and S. Y. W. Shiu, “Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer,” Journal of Pineal Research, vol. 51, no. 3, pp. 297–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. S. Joo and Y.-M. Yoo, “Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer,” Journal of Pineal Research, vol. 47, no. 1, pp. 8–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Rodriguez-Garcia, J. C. Mayo, D. Hevia, I. Quiros-Gonzalez, M. Navarro, and R. M. Sainz, “Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis,” Journal of Pineal Research, vol. 54, no. 1, pp. 33–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Culig, J. Stober, A. Gast et al., “Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone,” Cancer Detection and Prevention, vol. 20, no. 1, pp. 68–75, 1996. View at Google Scholar · View at Scopus
  29. D. Hevia, R. M. Sainz, D. Blanco et al., “Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion,” Journal of Pineal Research, vol. 45, no. 3, pp. 247–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. W. D. Tilley, J. M. Bentel, J. O. Aspinall, R. E. Hall, and D. J. Horsfall, “Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3,” Steroids, vol. 60, no. 1, pp. 180–186, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. M. B. Frungieri, A. Mayerhofer, K. Zitta, O. P. Pignataro, R. S. Calandra, and S. I. Gonzalez-Calvar, “Direct effect of melatonin on Syrian hamster testes: melatonin subtype 1a receptors, inhibition of androgen production, and interaction with the local corticotropin-releasing hormone system,” Endocrinology, vol. 146, no. 3, pp. 1541–1552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Yilmaz, S. Kutlu, R. Mogulkoc et al., “Melatonin inhibits testosterone secretion by acting at hypothalamo-pituitary-gonadal axis in the rat,” Neuroendocrinology Letters, vol. 21, no. 4, pp. 301–306, 2000. View at Google Scholar · View at Scopus
  33. A. Barbosa-Desongles, C. Hernández, I. De Torres et al., “Diabetes protects from prostate cancer by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model,” PLoS ONE, vol. 8, no. 9, Article ID e74179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. V. H. A. Cagnon, A. M. Camargo, R. M. Rosa, R. Fabiani, C. R. Padovani, and F. E. Martinez, “Ultrastructural study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57BL/6J),” Tissue and Cell, vol. 32, no. 4, pp. 275–283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. V. H. Cagnon and W. J. Fávaro, “Dystroglycan patterns on the prostate of non-obese diabetic mice submitted to glycaemic control,” International Journal of Experimental Pathology, vol. 90, no. 2, pp. 156–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. C. F. Carvalho, M. Camargo, V. H. Cagnon, and C. R. Padovani, “Effects of experimental diabetes on the structure and ultrastructure of the coagulating gland of C57BL/6J and NOD mice,” The Anatomical Record, vol. 270, no. 2, pp. 129–136, 2003. View at Google Scholar
  37. W. J. Fávaro, C. R. Padovani, and V. H. A. Cagnon, “Ultrastructural and proliferative features of the ventral lobe of the prostate in non-obese diabetic mice (NOD) following androgen and estrogen replacement associated to insulin therapy,” Tissue and Cell, vol. 41, no. 2, pp. 119–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. W. J. Fávaro and V. H. A. Cagnon, “Effect of combined hormonal and insulin therapy on the steroid hormone receptors and growth factors signalling in diabetic mice prostate,” International Journal of Experimental Pathology, vol. 91, no. 6, pp. 537–545, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. E. M. Porto, S. A. D. A. D. Santos, L. M. Ribeiro et al., “Lobe variation effects of experimental diabetes and insulin replacement on rat prostate,” Microscopy Research and Technique, vol. 74, no. 11, pp. 1040–1048, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. D. L. Ribeiro, E. J. Caldeira, E. M. Cândido, A. J. Manzato, S. R. Taboga, and V. H. Cagnon, “Prostatic stromal microenvironment and experimental diabetes,” European Journal of Histochemistry, vol. 50, no. 1, pp. 51–60, 2006. View at Google Scholar · View at Scopus
  41. C. Ye, X. Li, Y. Wang et al., “Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate,” Laboratory Investigation, vol. 91, no. 9, pp. 1363–1374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Yono, S. M. Mane, A. Lin, R. M. Weiss, and J. Latifpour, “Differential effects of diabetes induced by streptozotocin and that develops spontaneously on prostate growth in Bio Breeding (BB) rats,” Life Sciences, vol. 83, no. 5-6, pp. 192–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. F. O. Arcolino, D. L. Ribeiro, M. G. Gobbo, S. R. Taboga, and R. M. Goes, “Proliferation and apoptotic rates and increased frequency of p63-positive cells in the prostate acinar epithelium of alloxan-induced diabetic rats,” International Journal of Experimental Pathology, vol. 91, no. 2, pp. 144–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Burke, D. J. Jacobson, M. E. McGree et al., “Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota,” Urology, vol. 67, no. 1, pp. 22–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. M. G. Gobbo, S. R. Taboga, D. L. Ribeiro, and R. M. Góes, “Short-term stromal alterations in the rat ventral prostate following alloxan-induced diabetes and the influence of insulin replacement,” Micron, vol. 43, no. 2-3, pp. 326–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. D. L. Ribeiro, S. F. G. Marques, S. Alberti et al., “Malignant lesions in the ventral prostate of alloxan-induced diabetic rats,” International Journal of Experimental Pathology, vol. 89, no. 4, pp. 276–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Suthagar, S. Soudamani, S. Yuvaraj, A. Ismail Khan, M. M. Aruldhas, and K. Balasubramanian, “Effects of streptozotocin (STZ)-induced diabetes and insulin replacement on rat ventral prostate,” Biomedicine and Pharmacotherapy, vol. 63, no. 1, pp. 43–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Yono, M. Pouresmail, W. Takahashi, J. F. Flanagan, R. M. Weiss, and J. Latifpour, “Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 372, no. 3, pp. 251–255, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Chandrashekar, R. W. Steger, A. Bartke, C. T. Fadden, and S. G. Kienas, “Influence of diabetes on the gonadotropin response to the negative feedback effect of testosterone and hypothalamic neurotransmitter turnover in adult male rats,” Neuroendocrinology, vol. 54, no. 1, pp. 30–35, 1991. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Abiko, A. Abiko, A. C. Clermont et al., “Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation,” Diabetes, vol. 52, no. 3, pp. 829–837, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. N. E. Cameron, T. M. Gibson, M. R. Nangle, and M. A. Cotter, “Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes,” Annals of the New York Academy of Sciences, vol. 1043, pp. 784–792, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. G. S. A. Fernandes, C. D. B. Fernandez, K. E. Campos, D. C. Damasceno, J. A. Anselmo-Franci, and W. D. G. Kempinas, “Vitamin C partially attenuates male reproductive deficits in hyperglycemic rats,” Reproductive Biology and Endocrinology, vol. 9, no. 1, article 100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. M. G. Gobbo, D. L. Ribeiro, S. R. Taboga, E. A. de Almeida, and R. M. Góes, “Oxidative stress markers and apoptosis in the prostate of diabetic rats and the influence of vitamin C treatment,” Journal of Cellular Biochemistry, vol. 113, no. 7, pp. 2223–2233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Koya, I.-K. Lee, H. Ishii, H. Kanoh, and G. L. King, “Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol,” Journal of the American Society of Nephrology, vol. 8, no. 3, pp. 426–435, 1997. View at Google Scholar · View at Scopus
  55. R. Rahimi, S. Nikfar, B. Larijani, and M. Abdollahi, “A review on the role of antioxidants in the management of diabetes and its complications,” Biomedicine and Pharmacotherapy, vol. 59, no. 7, pp. 365–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. F. G. Amaral, A. O. Turati, M. Barone et al., “Melatonin synthesis impairment as a new deleterious outcome of diabetes-derived hyperglycemia,” Journal of Pineal Research, vol. 57, no. 1, pp. 67–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Wolden-Hanson, D. R. Mitton, R. L. McCants et al., “Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat,” Endocrinology, vol. 141, no. 2, pp. 487–497, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  59. N. L. McGuire, K. Kangas, and G. E. Bentley, “Effects of melatonin on peripheral reproductive function: regulation of testicular GnIH and testosterone,” Endocrinology, vol. 152, no. 9, pp. 3461–3470, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. L. Dubocovich and M. Markowska, “Functional MT1 and MT2 melatonin receptors in mammals,” Endocrine, vol. 27, no. 2, pp. 101–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. E. J. Sudnikovich, Y. Z. Maksimchik, S. V. Zabrodskaya et al., “Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rats,” European Journal of Pharmacology, vol. 569, no. 3, pp. 180–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Agil, M. Navarro-Alarcõn, R. Ruiz, S. Abuhamadah, M.-Y. El-Mir, and G. F. Vázquez, “Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats,” Journal of Pineal Research, vol. 50, no. 2, pp. 207–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Y. W. Shiu, W. Y. Leung, C. W. Tam, V. W. S. Liu, and K.-M. Yao, “Melatonin MT1 receptor-induced transcriptional up-regulation of p27Kip1 in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy,” Journal of Pineal Research, vol. 54, no. 1, pp. 69–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. M. G. Gobbo, C. F. P. Costa, D. G. H. Silva, E. A. Almeira, and R. M. Góes, “Biomarkers of oxidative stress in rat male reproductive organs under experimental diabetes and interference of melatonin treatment,” Oxidative Medicine and Cellular Longevity. In press.
  65. F. Radogna, L. Paternoster, M. C. Albertini et al., “Melatonin as an apoptosis antagonist,” Annals of the New York Academy of Sciences, vol. 1090, pp. 226–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Zhang, S. Zhao, L. Bai, M. Guan, J. Mo, and L. Lan, “Melatonin restores normal Bax and Bcl-2 protein expression in the subgranular zone of the dentate gyrus in pinealectomized rats,” Neural Regeneration Research, vol. 6, no. 27, pp. 2129–2133, 2011. View at Google Scholar · View at Scopus
  67. S.-C. Wang, “PCNA: a silent housekeeper or a potential therapeutic target?” Trends in Pharmacological Sciences, vol. 35, no. 4, pp. 178–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Limanowski, B. Miśkowiak, and B. Otulakowski, “Effects of melatonin, testosterone and the two hormones administered in parallel an ventral prostate of the rat treated with stilbestrol in the first day of life,” Histology and Histopathology, vol. 10, no. 4, pp. 869–874, 1995. View at Google Scholar · View at Scopus
  69. W. Srivilai, B. Withyachumnarnkul, and W. Trakulrungsi, “Stereological changes in rat ventral prostate induced by melatonin,” Journal of Pineal Research, vol. 6, no. 2, pp. 111–119, 1989. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. Lupowitz and N. Zisapel, “Hormonal interactions in human prostate tumor LNCaP cells,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 68, no. 1-2, pp. 83–88, 1999. View at Publisher · View at Google Scholar · View at Scopus
  71. R. M. Sainz, J. C. Mayo, D.-X. Tan, J. León, L. Manchester, and R. J. Reiter, “Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism,” Prostate, vol. 63, no. 1, pp. 29–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. D. Hevia, J. C. Mayo, I. Quiros, C. Gomez-Cordoves, and R. M. Sainz, “Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC,” Analytical and Bioanalytical Chemistry, vol. 397, no. 3, pp. 1235–1244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. D. L. Ribeiro, S. R. Taboga, and R. M. Góes, “Diabetes induces stromal remodelling and increase in chondroitin sulphate proteoglycans of the rat ventral prostate,” International Journal of Experimental Pathology, vol. 90, no. 4, pp. 400–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. D. Hevia, P. González-Menéndez, I. Quiros-González et al., “Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer,” Journal of Pineal Research, vol. 58, no. 2, pp. 234–250, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. A. M. De Marzo, W. G. Nelson, A. K. Meeker, and D. S. Coffey, “Stem cell features of benign and malignant prostate epithelial cells,” Journal of Urology, vol. 160, no. 6, pp. 2381–2392, 1998. View at Publisher · View at Google Scholar · View at Scopus